Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Mosquito-Borne Infections Testing Market CAGR Analysis And Future Market Development
The market for mosquito-borne infections testing has experienced robust expansion over recent years. Projections indicate that it will expand from $1.44 billion in 2025 to $1.56 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.8%. This historical growth is primarily due to several factors, including the rising incidence of dengue and malaria outbreaks, restricted availability of sophisticated diagnostic facilities in developing areas, heightened public understanding of the impact of vector-borne diseases, the enlargement of laboratory testing capabilities within urban health systems, and an increase in governmental financial support for initiatives aimed at controlling infectious diseases.
The mosquito-borne infections testing market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $2.12 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.0%. This anticipated growth is primarily driven by factors such as the expansion of mosquito habitats and disease transmission zones due to climate change, the greater uptake of rapid molecular diagnostic techniques, the advancement of real-time outbreak monitoring and predictive surveillance systems, the increasing need for integrated public health data reporting solutions, and the broadening application of personalized and precision diagnostics for infectious diseases. Key trends expected during this period involve a heightened occurrence of mosquito-borne outbreaks boosting the requirement for quick diagnostic tests, the broadening of decentralized and point-of-care testing services in remote and rural areas, the increasing use of multiplex assays for identifying multiple vector-borne pathogens concurrently, the proliferation of government-initiated surveillance and screening initiatives for timely outbreak identification, and a growing inclination towards portable and field-deployable diagnostic kits to enable a quicker epidemic response.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample_request?id=54773480&type=smp
Mosquito-Borne Infections Testing Market Demand Drivers: What Is Fueling Industry Growth?
The increasing occurrence of dengue illnesses is anticipated to boost the Mosquito Borne Infections Testing market’s expansion in the future. Dengue, a viral infection, is carried by mosquitoes, primarily aedes, and results from the dengue virus. The frequency of dengue cases is on the rise, attributed to higher temperatures and greater rainfall, which foster ideal breeding environments for aedes mosquitoes, alongside rapid urbanization that brings people into closer contact with mosquito populations. Testing for mosquito-borne infections facilitates the prompt identification and oversight of dengue infections by detecting the virus in individuals, allowing for quick medical responses and public health strategies to manage disease dissemination. For example, as reported by the World Health Organization, a Switzerland-based intergovernmental body, in July 2023, Brazil reported that among the 2,376,522 dengue cases documented until epidemiological week 26, 1,051,773 (44. 2%) were confirmed by laboratory tests, and 1,249 (0. 05%) were classified as severe dengue, representing a 13% surge compared to the corresponding period in 2022. Consequently, the escalating prevalence of dengue diseases is fueling the expansion of the mosquito borne infections testing market.
Mosquito-Borne Infections Testing Market Segmentation And Category Breakdown
The mosquito-borne infections testing market covered in this report is segmented –
1) By Test Type: Molecular Diagnostic Tests, Serological Tests, Rapid Antigen Tests, Polymerase Chain Reaction (PCR) Testing Services, Laboratory Reagent-Based Tests
2) By Sample Type: Blood Samples, Serum Samples, Plasma Samples, Urine Samples, Saliva Samples
3) By Infection Type: Dengue, Malaria, Zika Virus, Chikungunya, West Nile Virus, Other Infection Types
4) By Technology: Enzyme-Linked Immunosorbent Assay, Lateral Flow Assay, Polymerase Chain Reaction, Next-Generation Sequencing, Other Technologies
5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Public Health Agencies, Research Institutes, Point-Of-Care Settings
Subsegments:
1) By Molecular Diagnostic Tests: Nucleic Acid Amplification Testing, Reverse Transcription Polymerase Chain Reaction Testing, Multiplex Molecular Testing, Isothermal Amplification Testing, Pathogen Specific Genetic Testing
2) By Serological Tests: Immunoglobulin M Antibody Testing, Immunoglobulin G Antibody Testing, Antigen Detection Testing, Neutralization Assays, Enzyme Immunoassay Testing
3) By Rapid Antigen Tests: Point Of Care Antigen Testing, Lateral Flow Antigen Testing, Immunochromatographic Antigen Testing, Portable Rapid Diagnostic Testing, Field Based Antigen Testing
4) By Polymerase Chain Reaction Testing Services: Real Time Polymerase Chain Reaction Testing, Quantitative Polymerase Chain Reaction Testing, Multiplex Polymerase Chain Reaction Testing, Digital Polymerase Chain Reaction Testing, Reverse Transcription Polymerase Chain Reaction Testing
5) By Laboratory Reagent Based Tests: Reagent Kit Based Diagnostic Testing, Chemical Reaction Based Testing, Enzyme Reagent Testing, Staining Reagent Testing, Buffer Solution Based Testing
Mosquito-Borne Infections Testing Market Innovation Trends: Which Developments Are Transforming The Industry?
Companies operating in the mosquito-borne infections testing market are increasingly concentrating on developing innovative methodologies, such as automated high-throughput immunoassays, to achieve faster, more accurate, and scalable detection of mosquito-borne pathogens. These automated high-throughput immunoassays are laboratory examinations designed to automatically identify specific antigens or antibodies in a large volume of samples, thus enabling a rapid, precise, and scalable diagnosis of mosquito-borne infections compared to older manual techniques. For example, in October 2025, F. Hoffmann-La Roche Ltd., a biotechnology and diagnostics company from Switzerland, obtained CE mark for its Elecsys Dengue Ag test. This advanced automated immunoassay is specifically designed to identify the NS1 antigen of the dengue virus in human serum and plasma. The test functions on Roche’s fully automated cobas e analysers, delivering results in only 18 minutes and reliably detecting all four dengue virus serotypes. Key attributes include high clinical sensitivity and specificity, a medium-to-high throughput ranging from 120–300 tests per hour, enhanced traceability, and improved workflow efficiency, making it particularly useful for rapid patient management and surveillance during dengue outbreaks. The Elecsys Dengue Ag test represents a significant leap forward from conventional approaches, providing consistent, quick, and comprehensive diagnostic capabilities across the entire patient’s treatment journey.
Mosquito-Borne Infections Testing Market Competitive Analysis Of Major Industry Participants
Major companies operating in the mosquito-borne infections testing market are F. Hoffmann-La Roche Ltd, Trinity Biotech plc, Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings (LabCorp), Grifols S. A., Hologic Inc., bioMérieux SA, Bio-Rad Laboratories Inc., QIAGEN N. V., DiaSorin S. p. A., Euroimmun Medizinische Diagnostika AG, SD Biosensor Inc., Promega Corporation, Mayo Clinic Laboratories, Meridian Bioscience Inc., R-Biopharm AG, Boditech Med Inc., NanoEntek Inc., Entomogen Inc., J. Mitra and Co. Pvt. Ltd., Today’s Clinical Lab Pvt. Ltd., Co-Dx Inc.
Access The Complete Mosquito-Borne Infections Testing Market Report:
https://www.thebusinessresearchcompany.com/report/mosquito-borne-infections-testing-market-report
Mosquito-Borne Infections Testing Market Regional Analysis: Which Region Leads By Revenue?
Asia-Pacific was the largest region in the mosquito-borne infections testing market in 2025. Latin America is expected to be the fastest-growing region in the forecast period. The regions covered in the mosquito-borne infections testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.